PURPOSE: Desmin mutations in humans cause desmin-related cardiomyopathy, resulting in heart failure, atrial and ventricular arrhythmias, and sudden cardiac death. The intermediate filament desmin is strongly expressed in striated muscle cells and in Purkinje fibers of the ventricular conduction system. The aim of the present study was to characterize electrophysiological cardiac properties in a desmin-deficient mouse model. METHODS: The impact of desmin deficiency on cardiac electrophysiological characteristics was examined in the present study. In vivo electrophysiological studies were carried out in 29 adult desmin deficient (Des-/-) and 19 wild-type (Des+/+) mice. Additionally, epicardial activation mapping was performed in Langendorff-perfused hearts. RESULTS: Intracardiac electrograms showed no significant differences in AV, AH, and HV intervals. Functional testing revealed equal AV-nodal refractory periods, sinus-node recovery times, and Wenckebach points. However, compared to the wild-type situation, Des-/- mice were found to have a significantly reduced atrial (23.6+/-10.3 ms vs. 31.8+/-12.5 ms; p=0.045), but prolonged ventricular refractory period (33.0+/-8.7 ms vs. 26.7+/-6.5 ms; p=0.009). The probability of induction of atrial fibrillation was significantly higher in Des-/- mice (Des-/-: 38% vs. Des+/+: 27%; p=0.0255), while ventricular tachycardias significantly were reduced (Des-/-: 7% vs. Des+/+: 21%; p<0.0001). Epicardial activation mapping showed slowing of conduction in the ventricles of Des-/- mice. CONCLUSIONS: Des-/- mice exhibit reduced atrial but prolonged ventricular refractory periods and ventricular conduction slowing, accompanied by enhanced inducibility of atrial fibrillation and diminished susceptibility to ventricular arrhythmias. Desmin deficiency does not result in electrophysiological changes present in human desminopathies, suggesting that functional alterations rather than loss of desmin cause the cardiac alterations in these patients.
PURPOSE:Desmin mutations in humans cause desmin-related cardiomyopathy, resulting in heart failure, atrial and ventricular arrhythmias, and sudden cardiac death. The intermediate filament desmin is strongly expressed in striated muscle cells and in Purkinje fibers of the ventricular conduction system. The aim of the present study was to characterize electrophysiological cardiac properties in a desmin-deficient mouse model. METHODS: The impact of desmin deficiency on cardiac electrophysiological characteristics was examined in the present study. In vivo electrophysiological studies were carried out in 29 adult desmin deficient (Des-/-) and 19 wild-type (Des+/+) mice. Additionally, epicardial activation mapping was performed in Langendorff-perfused hearts. RESULTS: Intracardiac electrograms showed no significant differences in AV, AH, and HV intervals. Functional testing revealed equal AV-nodal refractory periods, sinus-node recovery times, and Wenckebach points. However, compared to the wild-type situation, Des-/- mice were found to have a significantly reduced atrial (23.6+/-10.3 ms vs. 31.8+/-12.5 ms; p=0.045), but prolonged ventricular refractory period (33.0+/-8.7 ms vs. 26.7+/-6.5 ms; p=0.009). The probability of induction of atrial fibrillation was significantly higher in Des-/- mice (Des-/-: 38% vs. Des+/+: 27%; p=0.0255), while ventricular tachycardias significantly were reduced (Des-/-: 7% vs. Des+/+: 21%; p<0.0001). Epicardial activation mapping showed slowing of conduction in the ventricles of Des-/- mice. CONCLUSIONS:Des-/- mice exhibit reduced atrial but prolonged ventricular refractory periods and ventricular conduction slowing, accompanied by enhanced inducibility of atrial fibrillation and diminished susceptibility to ventricular arrhythmias. Desmin deficiency does not result in electrophysiological changes present in humandesminopathies, suggesting that functional alterations rather than loss of desmin cause the cardiac alterations in these patients.
Authors: Rolf Schröder; Bertrand Goudeau; Monique Casteras Simon; Dirk Fischer; Thomas Eggermann; Christoph S Clemen; Zhenlin Li; Jens Reimann; Zhigang Xue; Sabine Rudnik-Schöneborn; Klaus Zerres; Peter F M van der Ven; Dieter O Fürst; Wolfram S Kunz; Patrick Vicart Journal: Hum Mol Genet Date: 2003-03-15 Impact factor: 6.150
Authors: Jan W Schrickel; Klara Brixius; Claudia Herr; Christoph S Clemen; Philipp Sasse; Kathrin Reetz; Christian Grohé; Rainer Meyer; Klaus Tiemann; Rolf Schröder; Wilhelm Bloch; Georg Nickenig; Bernd K Fleischmann; Angelika A Noegel; Robert H G Schwinger; Thorsten Lewalter Journal: Cardiovasc Res Date: 2007-07-06 Impact factor: 10.787
Authors: O Traub; R Eckert; H Lichtenberg-Fraté; C Elfgang; B Bastide; K H Scheidtmann; D F Hülser; K Willecke Journal: Eur J Cell Biol Date: 1994-06 Impact factor: 4.492
Authors: A M Sprinkart; W Block; F Träber; R Meyer; D Paulin; C S Clemen; R Schröder; J Gieseke; H Schild; D Thomas Journal: Int J Cardiovasc Imaging Date: 2011-12-09 Impact factor: 2.357
Authors: Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain Journal: Prog Mol Biol Transl Sci Date: 2012 Impact factor: 3.622
Authors: Christine A Henderson; Christopher G Gomez; Stefanie M Novak; Lei Mi-Mi; Carol C Gregorio Journal: Compr Physiol Date: 2017-06-18 Impact factor: 9.090
Authors: Bianca J J M Brundel; Xun Ai; Mellanie True Hills; Myrthe F Kuipers; Gregory Y H Lip; Natasja M S de Groot Journal: Nat Rev Dis Primers Date: 2022-04-07 Impact factor: 52.329